Adlard N - Search Results

1

Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis.

Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N. Samjoo IA, et al. Among authors: adlard n. J Comp Eff Res. 2020 Dec;9(18):1255-1274. doi: 10.2217/cer-2020-0122. Epub 2020 Oct 22. J Comp Eff Res. 2020. PMID: 33090003 Free article.

2

Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England.

Maruszczak MJ, Montgomery SM, Griffiths MJ, Bergvall N, Adlard N. Maruszczak MJ, et al. Among authors: adlard n. J Med Econ. 2015;18(11):874-85. doi: 10.3111/13696998.2015.1056794. Epub 2015 Jul 1. J Med Econ. 2015. PMID: 26055952 Free article.

3

Systematic literature review and network meta-analysis in highly active relapsing-remitting multiple sclerosis and rapidly evolving severe multiple sclerosis.

Huisman E, Papadimitropoulou K, Jarrett J, Bending M, Firth Z, Allen F, Adlard N. Huisman E, et al. Among authors: adlard n. BMJ Open. 2017 Mar 10;7(3):e013430. doi: 10.1136/bmjopen-2016-013430. BMJ Open. 2017. PMID: 28283486 Free PMC article. Review.

4

When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing-remitting multiple sclerosis.

Noon KM, Montgomery SM, Adlard NE, Kroes MA. Noon KM, et al. J Med Econ. 2018 Oct;21(10):983-992. doi: 10.1080/13696998.2018.1491007. Epub 2018 Jul 5. J Med Econ. 2018. PMID: 29923439 Free article.

5

The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis.

Samjoo IA, Worthington E, Haltner A, Cameron C, Nicholas R, Dahlke F, Adlard N. Samjoo IA, et al. Among authors: adlard n. Curr Med Res Opin. 2020 Jul;36(7):1145-1156. doi: 10.1080/03007995.2020.1747998. Epub 2020 Apr 14. Curr Med Res Opin. 2020. PMID: 32216597

6

Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis.

Samjoo IA, Worthington E, Haltner A, Cameron C, Nicholas R, Rouyrre N, Dahlke F, Adlard N. Samjoo IA, et al. Among authors: adlard n. Curr Med Res Opin. 2020 Jul;36(7):1157-1166. doi: 10.1080/03007995.2020.1747999. Epub 2020 Apr 14. Curr Med Res Opin. 2020. PMID: 32220214

7

Efficacy classification of modern therapies in multiple sclerosis.

Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N. Samjoo IA, et al. Among authors: adlard n. J Comp Eff Res. 2021 Apr;10(6):495-507. doi: 10.2217/cer-2020-0267. Epub 2021 Feb 23. J Comp Eff Res. 2021. PMID: 33620251 Free article.

8

Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses.

Samjoo IA, Worthington E, Haltner A, Spin P, Drudge C, Cameron C, Brennan R, Dahlke F, Adlard N. Samjoo IA, et al. Among authors: adlard n. Curr Med Res Opin. 2021 Nov;37(11):1933-1944. doi: 10.1080/03007995.2021.1968362. Epub 2021 Aug 26. Curr Med Res Opin. 2021. PMID: 34384311

9

Letter in reply.

Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N. Samjoo IA, et al. Among authors: adlard n. J Comp Eff Res. 2021 Dec;10(17):1267-1269. doi: 10.2217/cer-2021-0203. Epub 2021 Oct 5. J Comp Eff Res. 2021. PMID: 34608814 Free article. No abstract available.

10

Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis.

Samjoo IA, Klotz L, Giovannoni G, Drudge C, Haltner A, Worthington E, Zhao M, Brennan R, Häring DA, Cameron C, Adlard N. Samjoo IA, et al. Among authors: adlard n. Mult Scler Relat Disord. 2022 Oct;66:104031. doi: 10.1016/j.msard.2022.104031. Epub 2022 Jul 4. Mult Scler Relat Disord. 2022. PMID: 35841716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters